Aurinia Pharmaceuticals AUPH Total debt

Total debt at other companies

Rogers CorporationROG

$28.5M-14.2%

Vera TherapeuticsVERA

$75.03M+37.8%

ANI PharmaceuticalsANIP

$301.48M-4.2%

Theravance BiopharmaTBPH

$40.5M-15.9%

Opko HealthOPK

$49.94M-7.5%

LQD

Liquidia CorporationLQDA

$6.96M+1.5%

FAQ

What is Aurinia Pharmaceuticals's total debt?

Aurinia Pharmaceuticals (AUPH) reported total debt of $80.62M in Q2 2026.

How has Aurinia Pharmaceuticals's total debt changed year-over-year?

Aurinia Pharmaceuticals's total debt decreased by 17.7% year-over-year, from $98M to $80.62M.

What is the long-term trend for Aurinia Pharmaceuticals's total debt?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total debt has grown at a 61.1% compound annual growth rate (CAGR), from $8.41M to $91.34M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.